Exodus Technology
Nanoparticle-based, Non-drug Solution for Targeted, Permanent Chronic Pain Relief
Company Overview
Snapshot
Founded in January 2023 by Michael Zilbershlag, Exodus Technology operates with 1–10 employees. The company has raised $150,000 across one funding round from one investor. Exodus Technology is developing a nanoparticle-based solution for targeted, permanent chronic pain relief.
Business overview
Exodus Technology, also known as Nano Painkiller, is developing Focus Pain Ablation (FPA) technology, a non-drug solution for chronic pain relief. This innovation utilizes gold nanoparticles conjugated with a neuronal tracer, injected into the painful area and activated by external ultrasound energy to selectively destroy sensory nerve cells in the Dorsal Root Ganglion. The technology aims to provide a permanent solution for chronic pain, addressing the limitations and risks of current systemic drug therapies and repeat-intensive procedures. The company primarily targets the medical devices sector within Health Tech & Life Sciences, with an initial focus on Knee Osteoarthritis Pain, serving markets in Asia, North America, and Europe.
Strategic signal
In October 2025, Exodus Technology's nanoparticle-based solution for chronic pain was highlighted for its potential to save billions in traditional painkiller costs and target a $78 billion market opportunity. This signals a strong market validation for their non-drug approach, positioning the company as a significant innovator in addressing the global burden of chronic pain and reducing reliance on opioids.
Log in to access full profile ›Company Intelligence Q&A
- What is Exodus Technology's core product?
- Exodus Technology's core product is Focus Pain Ablation (FPA) technology, a nanoparticle-based, non-drug solution designed for targeted and permanent chronic pain relief.
- When was Exodus Technology founded?
- Exodus Technology was founded in January 2023.
- Who is the founder of Exodus Technology?
- Michael Zilbershlag is the founder of Exodus Technology.
- What is the primary market opportunity for Exodus Technology?
- The primary business opportunity for Exodus Technology is to replace repeat-intensive procedures and long-term drug dependence with a permanent solution for chronic pain, initially targeting Knee Osteoarthritis Pain.
- What is the total funding raised by Exodus Technology?
- Exodus Technology has raised $150,000 in Pre-Seed funding across one round. The funding was secured from one investor.